New Pharmacogenomics Research Network: An Open Community Catalyzing Research and Translation in Precision Medicine

M. V. Relling, R. M. Krauss, D. M. Roden, T. E. Klein, D. M. Fowler, N. Terada, L. Lin, M. Riel-Mehan, T. P. Do, M. Kubo, S. W. Yee, G. T. Johnson, K. M. Giacomini

Research output: Contribution to journalComment/debate

15 Citations (Scopus)

Abstract

The goal of pharmacogenomics research is to discover genetic polymorphisms that underlie variation in drug response. Increasingly, pharmacogenomics research involves large numbers of patients and the application of new technologies and methodologies to enable discovery. The Pharmacogenomics Research Network (PGRN) has become a community-driven network of investigators spanning scientific and clinical disciplines. Here, we highlight the activities and types of resources that enable PGRN members to enhance and drive basic and translational research in pharmacogenomics.

Original languageEnglish
Pages (from-to)897-902
Number of pages6
JournalClinical Pharmacology and Therapeutics
Volume102
Issue number6
DOIs
Publication statusPublished - 12-2017

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'New Pharmacogenomics Research Network: An Open Community Catalyzing Research and Translation in Precision Medicine'. Together they form a unique fingerprint.

  • Cite this

    Relling, M. V., Krauss, R. M., Roden, D. M., Klein, T. E., Fowler, D. M., Terada, N., Lin, L., Riel-Mehan, M., Do, T. P., Kubo, M., Yee, S. W., Johnson, G. T., & Giacomini, K. M. (2017). New Pharmacogenomics Research Network: An Open Community Catalyzing Research and Translation in Precision Medicine. Clinical Pharmacology and Therapeutics, 102(6), 897-902. https://doi.org/10.1002/cpt.755